KKR & Co Inc vs Moderna, Inc. — how do they compare? KKR & Co Inc trades at $111.14 (market cap $99.61B), while Moderna, Inc. trades at $60.76 (market cap $24.18B). The key difference: KKR & Co Inc is far larger — about 4.1× Moderna, Inc.'s market cap, and KKR & Co Inc pays a 0.7% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| KKR | MRNA | |
|---|---|---|
Market Cap | $99.61B | $24.18B |
Sector | Financials | Health |
52-Week High | $149.34 | $81.80 |
52-Week Low | $83.88 | $22.36 |
Enterprise Value | $22.17B | $20.33B |
Dividend Yield | 0.7% | — |
Trailing returns across standard periods
Latest headlines on both assets
KKR is one of the world's largest alternative asset managers, with $490.7 billion in total assets under management, including $384.5 billion in fee-earning AUM, at the end of June 2022. The company has two core segments: asset management (which includes private markets--private equity, credit, infrastructure, energy and real estate--and public markets--primarily credit and hedge/investment fund platforms) and insurance (following the February 2021 purchase of a 61.5% economic stake in Global Atlantic Financial Group, which is engaged in retirement/annuity and life insurance lines as well as reinsurance). On the asset management side, private markets account for 50% of fee-earning AUM and 70% of base management fees, while public markets account for 50% and 30%, respectively.
Read more on KKR →Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →